Kneat Achieves Record Results in Growth and Profitability
November 06, 2024 17:04 ET
|
kneat.com, inc.
Kneat achieves record results in growth and profitability, as third-quarter 2024 revenue and gross profit growth accelerate to 52% and 78% respectively,
Global Medical Devices Manufacturer Selects Kneat to Digitize Validation
October 31, 2024 17:13 ET
|
kneat.com, inc.
Kneat signs a global and diverse medical devices manufacturer for digital validation.
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024
October 30, 2024 17:17 ET
|
kneat.com, inc.
Kneat to Announce 2024 Third-Quarter Financial Results November 6, 2024, and Host an Earnings Call on November 7
Kneat Announces Closing of $35.6 Million Bought Deal
October 10, 2024 10:17 ET
|
kneat.com, inc.
Kneat closed its previously announced bought deal, issuing 7,500,000 shares for gross proceeds to the Company of $35.6 million.
Global Pharma Selects Kneat to Digitize Computer System Validation
October 08, 2024 17:04 ET
|
kneat.com, inc.
Another global pharmaceutical company selects Kneat to digitize its validation processes.
Kneat Files Final Short Form Prospectus in Connection with Bought Deal Equity Financing and Obtains Receipt of Final Prospectus
October 07, 2024 17:03 ET
|
kneat.com, inc.
Kneat filed a final short-form prospectus, which qualifies the distribution of common shares in connection with its previously announced bought deal.